TranSOP: Transformer-based Multimodal Classification for Stroke Treatment Outcome Prediction

Acute ischaemic stroke, caused by an interruption in blood flow to brain tissue, is a leading cause of disability and mortality worldwide. The selection of patients for the most optimal ischaemic stroke treatment is a crucial step for a successful outcome, as the effect of treatment highly depends on the time to treatment. We propose a transformer-based multimodal network (TranSOP) for a classification approach that employs clinical metadata and imaging information, acquired on hospital admission, to predict the functional outcome of stroke treatment based on the modified Rankin Scale (mRS). This includes a fusion module to efficiently combine 3D non-contrast computed tomography (NCCT) features and clinical information. In comparative experiments using unimodal and multimodal data on the MRCLEAN dataset, we achieve a state-of-the-art AUC score of 0.85.

Prediction of Thrombectomy Functional Outcomes using Multimodal Data

Recent randomised clinical trials have shown that patients with ischaemic stroke {due to occlusion of a large intracranial blood vessel} benefit from endovascular thrombectomy. However, predicting outcome of treatment in an individual patient remains a challenge. We propose a novel deep learning approach to directly exploit multimodal data (clinical metadata information, imaging data, and imaging biomarkers extracted from images) to estimate the success of endovascular treatment. We incorporate an attention mechanism in our architecture to model global feature inter-dependencies, both channel-wise and spatially. We perform comparative experiments using unimodal and multimodal data, to predict functional outcome (modified Rankin Scale score, mRS) and achieve 0.75 AUC for dichotomised mRS scores and 0.35 classification accuracy for individual mRS scores.